Form 4/A for BBNX Beta Bionics, Inc.
Accepted 2026-09-18 19:51:40 ET · period of report 2026-09-09 · accession 0002048497-26-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AT | 2026-09-18 19:51 | 2026-09-09 | BBNX | Hopman Mark | Chief Commercial Off | S - Sale | $18.46 | -36.0K | 88.0K | -29% | -$664.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-09 | S | D | 35,994 | $18.46 | 88,033 | D | — | — | (F1) Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026 (the "10b5-1 Plan"). (F2) On September 10, 2026, the reporting person filed a Form 4 which incorrectly reported the number of shares disposed. The reporting person sold 35,994 shares under the 10b5-1 Plan on September 9, 2026 and the number of securities beneficially owned following the sale was 88,033 shares. (F2) On September 10, 2026, the reporting person filed a Form 4 which incorrectly reported the number of shares disposed. The reporting person sold 35,994 shares under the 10b5-1 Plan on September 9, 2026 and the number of securities beneficially owned following the sale was 88,033 shares. |